01:15 AM EST, 11/12/2026 (MT Newswires) -- DocMorris (DOCM.SW) tightened its guidance for full-year 2026 revenue, according to a Thursday release. The Switzerland-listed online pharmacy company now expects revenue for the year to grow 15%, compared with previous expectations of an increase of 12.5% to 15%.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.